View the MBGL.US chart to track price changes. The latest news and complete market analysis by Admirals to help you with stock trading and investing today.

View the PREC.SE chart to track price changes. The latest news and complete market analysis by Admirals to help you with stock trading and investing today.

Harrow Inc shares are lower in after-market hours amid broad weakness in the Pharmaceuticals sub-sector, with the price significantly below its 20-day moving average. Archer-Daniels-Midland shares are ...

Harrow Inc shares are lower in after-market hours amid broad weakness in the Pharmaceuticals sub-sector, with the price significantly below its 20-day moving average. Sprinklr Inc. shares are higher ...

View the METSO.FI chart to track price changes. The latest news and complete market analysis by Admirals to help you with stock trading and investing today.

Ready to trade with a broker that takes it as seriously as you do? Join traders who`ve already made the switch. No demo pressure. No hidden fees. Just infrastructure that holds up when the market ...

The title of dividend aristocrat is bestowed upon companies within the S&P 500 index which have raised their annual dividends every year for at least 25 consecutive years. These dividend aristocrats ...

Last week, Freeport-McMoRan released its Q2 results. Learn about its earnings report, financial performance and what analysts ...

ASML Holding, Europe’s largest company by market capitalisation, holds a global monopoly on extreme ultraviolet (EUV) lithography machines, which are required to produce the world's most advanced ...

A moving average looks at an asset's price over a set number of periods, finds the average and recalculates that average as each new period takes place. The result is a smoothed line that filters out ...

Resultados pasados no son un indicador fiable de resultados futuros.

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, ...